Literature DB >> 2148503

[Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study].

F Casazza1, F Ferrari, U Piccone, S Maggiolini, A Capozi, M Morpurgo.   

Abstract

Clinical, electrocardiographic and echocardiographic 5-year follow-up was performed in our institution on 61 patients with Friedreich's ataxia. Cardiac failure was evident in 5% of the patients, and was the most common cause of death. Cardiac arrhythmias, most commonly supraventricular in origin, usually occurred together with the onset of cardiac failure and in 1 case resulted in sudden death. ST-T abnormalities were present in 91% of the cases, and were independent from other clinical parameters. On the contrary, pseudonecrotic (5%) and right ventricular hypertrophy pattern were associated with a poor prognosis. Left ventricular hypertrophy was evident at the echocardiogram in 75% of cases and remained unchanged throughout the entire follow-up period. In 1 case left ventricular hypertrophy turned to dilative cardiomyopathy. Autopsy was performed in 2 out of 4 decreased patients and revealed massive interstitial fibrosis with cellular degeneration in the absence of coronary lesions.

Entities:  

Mesh:

Year:  1990        PMID: 2148503

Source DB:  PubMed          Journal:  Cardiologia        ISSN: 0393-1978


  4 in total

Review 1.  Friedreich's Ataxia: a review from a cardiology perspective.

Authors:  T Bourke; D Keane
Journal:  Ir J Med Sci       Date:  2011-08-07       Impact factor: 1.568

Review 2.  [The various forms of left ventricular hypertrophy: diagnostic value of echocardiography].

Authors:  F Weidemann; S Störk; S Herrmann; G Ertl; M Niemann
Journal:  Herz       Date:  2011-12       Impact factor: 1.443

3.  Chest pain during exercise as first manifestation of Friedreich's ataxia.

Authors:  P Ferrés-Sánchez; M Subirana-Domènech; M Torner-Soler
Journal:  Br Heart J       Date:  1995-10

4.  Pre-clinical left ventricular myocardial remodeling in patients with Friedreich's ataxia: A cardiac MRI study.

Authors:  Karen A G Takazaki; Thiago Quinaglia; Thiago D Venancio; Alberto R M Martinez; Ravi V Shah; Tomas G Neilan; Michael Jerosch-Herold; Otávio R Coelho-Filho; Marcondes C França
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.